Our heavy reliance on multinational pharmaceutical companies cannot be overstated – this sector is critical to the economy ...

The DAP facility consisted of a 480 square feet, two room suite with an office space and a separate, unclassified production ...

Fintel reports that on July 1, 2025, Barclays upgraded their outlook for Ionis Pharmaceuticals (NasdaqGS:IONS) from ...

The results of technology research and development must find their way into the published literature. New models of regulation could help.

Historically, pharmaceutical drugs have been manufactured in the U.S., but this is no longer the case, with only 28 percent of manufacturers of active pharmaceutical ingredients (APIs) in the ...

JIANGSU, China and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological ...

Fintel reports that on January 10, 2025, Needham upgraded their outlook for Collegium Pharmaceutical (NasdaqGS:COLL) from Hold to Buy. Analyst Price Forecast Suggests 29.26% Upside As of December ...

Fintel reports that on August 20, 2024, Bernstein upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from Market Perform to Outperform.. Analyst Price Forecast Suggests 17.67% ...

Recent legislation mandates that women with medical backgrounds register for military service starting Oct. 1, but, unless they are mobilized, they wouldn’t be restricted from leaving Ukraine.

Fintel reports that on August 28, 2023, HC Wainwright & Co. downgraded their outlook for Timber Pharmaceuticals from Buy to Neutral.. Analyst Price Forecast Suggests 270.30% Upside. As of August 2 ...

Specialty pharmaceuticals are a rapidly growing share of total drug expenditures by public and private health plans. These drugs, typically used to treat chronic, serious, or life-threatening ...